Bob C. Lin

Also affiliated with Institut de Recherche Vaccinale, National Institute of Allergy and Infectious Diseases, National Institutes of Health Clinical Center

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 62 papers. Top paper: “Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination”.

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

New England Journal of Medicine(2020)10.1056/nejmc2032195

N/A

18.5DataRank · unranked

831 citations

Nadine Rouphael, Lisa A. Jackson, Evan J. Anderson, Paul C. Roberts, Mamodikoe Makhene +26 more

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

New England Journal of Medicine(2024)10.1056/nejmoa2312775

N/A

2.6DataRank · unranked

84 citations

Aïssata Ongoïba, Anne C Preston, Sara A. Healy, Zonghui Hu, Jeff Skinner +38 more

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00098-9

N/A

2.5DataRank · unranked

67 citations

Kaitlyn M. Morabito, Emily Phung, Michelle C. Crank, Pamela Costner, LaSonji A. Holman +74 more

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Science Translational Medicine(2023)10.1126/scitranslmed.ade4790

N/A

1.9DataRank · unranked

96 citations

Amelia R. Hofstetter, Katherine V. Houser, Seemal F. Awan, Grace Chen, Maria Claudia Burgos Florez +95 more

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine

Science Translational Medicine(2022)10.1126/scitranslmed.ade0424

N/A

1.8DataRank · unranked

47 citations

Emily Phung, Michelle C. Crank, Kaitlyn M. Morabito, Tonya Villafana, Filip Dubovsky +7 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(22)00793-9

N/A

1.2DataRank · unranked

41 citations

Andrea A. Berry, Kaitlin Mason, Azza H. Idris, Mark O’Callahan, Myra Happe +95 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

New England Journal of Medicine(2020)10.1056/nejmoa2028436

N/A

1.1DataRank · unranked

1633 citations

Nadine Rouphael, Alicia T. Widge, Lisa A. Jackson, Paul C. Roberts, Mamodikoe Makhene +32 more

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00344-4

N/A

1.0DataRank · unranked

24 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Prossy Naluyima, Francis Kiweewa +70 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell(2022)10.1016/j.cell.2022.09.032

N/A

0.637DataRank · unranked

69 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

Nature Communications(2023)10.1038/s41467-023-42098-5

N/A

0.613DataRank · unranked

25 citations

S. Pletnev, Adam S. Olia, Kai Xu, Baoshan Zhang, Reda Rawi +21 more

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1–Exposed Newborn Infants

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab229

N/A

0.598DataRank · unranked

53 citations

Coleen K. Cunningham, Petronella Muresan, Edmund V. Capparelli, Charlotte Perlowski, Patricia Morgan +44 more

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency

Scientific Reports(2022)10.1038/s41598-022-12423-x

N/A

0.416DataRank · unranked

15 citations

Nicole A. Doria‐Rose, Nicole A. Schneck, Vera B. Ivleva, Brad Tippett, William R. Shadrick +17 more

Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains

Nature Communications(2024)10.1038/s41467-024-48514-8

N/A

0.409DataRank · unranked

8 citations

Kun‐Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu +18 more

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

JCI Insight(2024)10.1172/jci.insight.175375

N/A

0.404DataRank · unranked

7 citations

Amarendra Pegu, Larisa Strom, Cristina Carter, Cynthia S. Hendel, LaSonji A Holman +32 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals

medRxiv(2024)10.1101/2024.03.15.24304305

N/A

0.375DataRank · unranked

7 citations

Wilton B. Williams, Stephen R. Walsh, Derek W. Cain, Matthew Clark, Ryan Tuck +38 more

Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

mAbs(2020)10.1080/19420862.2020.1836719

N/A

0.345DataRank · unranked

9 citations

Mangaiarkarasi Asokan, Vera B. Ivleva, Amarendra Pegu, Eun Sung Yang, Baoshan Zhang +14 more

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults

The Lancet HIV(2025)10.1016/s2352-3018(25)00041-4

N/A

0.335DataRank · unranked

8 citations

Katherine V. Houser, Martin R. Gaudinski, Alicia T. Widge, Seemal F. Awan, Cristina Carter +95 more

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies

Cell Reports(2024)10.1016/j.celrep.2024.115010

N/A

0.332DataRank · unranked

7 citations

Chen‐Hsiang Shen, Adam S. Olia, Nathan A. Radakovich, Reda Rawi, Yongping Yang +24 more

Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage

Cell Reports(2025)10.1016/j.celrep.2024.115223

N/A

0.269DataRank · unranked

5 citations

Baoshan Zhang, Nicholas C. Morano, Chen‐Hsiang Shen, Krisha McKee, Ashley Heimann +13 more

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial

JCI Insight(2025)10.1172/jci.insight.191266

N/A

0.104DataRank · unranked

1 citations

Catriona A. Wagner, Ashley Pinckney, Jeffrey A. Cohen, Zachary S. Wallace, Arezou Khosroshahi +36 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1

Advanced Science(2024)10.1002/advs.202309268

N/A

0DataRank · unranked

6 citations

Tongqing Zhou, Krisha McKee, Baoshan Zhang, Cuiping Liu, Alexandra F. Nazzari +29 more

Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection

Cell Reports(2025)10.1016/j.celrep.2025.115557

N/A

0DataRank · unranked

7 citations

James Lim, Clarisa M. Buckner, Felipe Lopes de Assis, Xiaozhen Zhang, Wei Wang +17 more

Antigen Dose and Persistence Contribute to Induction of a Durable HIV-1-Specific Neutralizing Antibody Response

Research Square(2024)10.21203/rs.3.rs-5589251/v1

N/A

0DataRank · unranked

0 citations

Kenta Matsuda, Mitra Harrison, Eleanor Wettstein, Jessica Pederson, Alyssa A. Pullano +39 more

Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response

Nature Communications(2025)10.1038/s41467-025-60481-2

N/A

0DataRank · unranked

1 citations

Mitra Harrison, Eleanor Wettstein, Jessica Pederson, Alyssa A. Pullano, Lyuba Bolkhovitinov +39 more

Hyaluronidase-enhanced subcutaneous delivery of bNAbs: a phase 1 randomized controlled clinical trial in HIV-uninfected women

Nature Communications(2025)10.1038/s41467-025-63051-8

N/A

0DataRank · unranked

1 citations

Farzana Osman, Martin Béliveau, Roberto Heredia‐Ortiz, Kevin Carlton, Jennifer Wang +10 more

Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody

medRxiv(2025)10.1101/2025.09.04.25334949

N/A

0DataRank · unranked

1 citations

Nonhlanhla N. Mkhize, Leonid Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Haajira Kaldine +15 more

HI-CeFSpot: High-throughput Immune Cell FluoroSpot assay

Methods(2025)10.1016/j.ymeth.2025.10.002

N/A

0DataRank · unranked

0 citations

Matthew S. Sutton, Robin Carroll, Rachel Kazmierski, Kwang Low, Maleeha Mughal +15 more

Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization Breadth

Vaccines(2025)10.3390/vaccines13111098

N/A

0DataRank · unranked

0 citations

S. Pletnev, Bharat Madan, Phinikoula S. Katsamba, Krisha McKee, Nicholas C. Morano +15 more

A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf572

N/A

0DataRank · unranked

0 citations

Lauren Dang, Eric Chun‐Pu Chu, Jonathan Fintzi, Holly Janes, Peter B. Gilbert +13 more

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth

Science(2020)10.1126/science.abd2638

N/A

0DataRank · unranked

103 citations

Hui Li, Wilton B. Williams, Hema Chug, Rosemarie D. Mason, Jason Gorman +52 more

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life

Clinical Infectious Diseases(2020)10.1093/cid/ciaa648

N/A

0DataRank · unranked

78 citations

Barney S. Graham, Awa Traoré, Fadima Cheick Haidara, Man Chen, Kaitlyn M. Morabito +6 more

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2026

N/A

0DataRank · unranked

10 citations

Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Emily E. Coates, Katherine V. Houser +10 more

VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage

Cell Host & Microbe(2020)10.1016/j.chom.2020.01.027

N/A

0DataRank · unranked

32 citations

Brandon J. DeKosky, Yicheng Guo, Kai Xu, Ying Gu, Divya Kilam +31 more

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine(2021)10.1056/nejmc2103916

N/A

0DataRank · unranked

758 citations

Mehul S. Suthar, Mat Makowski, Sarah O’Connell, Adrian B. McDermott, Britta Flach +25 more

Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth

Immunity(2021)10.1016/j.immuni.2020.12.014

N/A

0DataRank · unranked

73 citations

Tongqing Zhou, Stephen D. Schmidt, Hongying Duan, Cheng Cheng, Gwo‐Yu Chuang +14 more

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies

Cell Reports(2021)10.1016/j.celrep.2021.109922

N/A

0DataRank · unranked

18 citations

Kartik Manne, Rui Kong, Shuishu Wang, Tongqing Zhou, Gwo‐Yu Chuang +22 more

Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2011653118

N/A

0DataRank · unranked

31 citations

Baoshan Zhang, Kai Xu, Cara W. Chao, Sijy O’Dell, Jacy R. Wolfe +18 more

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention

mAbs(2021)10.1080/19420862.2021.1946918

N/A

0DataRank · unranked

25 citations

Mangaiarkarasi Asokan, Jason Gorman, Baoshan Zhang, Qingbo Liu, Mark K. Louder +12 more

Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces

Nature Communications(2021)10.1038/s41467-021-26579-z

N/A

0DataRank · unranked

9 citations

Anita Changela, Jason Gorman, Reda Rawi, Tatsiana Bylund, Cara W. Chao +10 more

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

Cell(2022)10.1016/j.cell.2022.03.038

N/A

0DataRank · unranked

228 citations

Juan I. Moliva, Kathryn E. Foulds, Shayne F. Andrew, Barbara J. Flynn, Anne P. Werner +72 more

Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site

Structure(2022)10.1016/j.str.2022.03.012

N/A

0DataRank · unranked

17 citations

Lei Chen, Jason Gorman, Shuishu Wang, Young Do Kwon, Bob C. Lin +14 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Scientific Reports(2022)10.1038/s41598-022-22435-2

N/A

0DataRank · unranked

14 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479037

N/A

0DataRank · unranked

51 citations

Juan I. Moliva, Kathryn E. Foulds, Shayne F. Andrew, Barbara J. Flynn, Anne P. Werner +61 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination

medRxiv(2022)10.1101/2022.08.30.22279344

N/A

0DataRank · unranked

1 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Research Square(2022)10.21203/rs.3.rs-1534769/v1

N/A

0DataRank · unranked

0 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection

Neurology Neuroimmunology & Neuroinflammation(2023)10.1212/nxi.0000000000200097

N/A

0DataRank · unranked

54 citations

Yoshimi Enose‐Akahata, Dima A. Hammoud, Anthony J. Videckis, Sandeep Narpala, Sarah O’Connell +12 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

Journal of Virology(2023)10.1128/jvi.01604-22

N/A

0DataRank · unranked

16 citations

Anita Changela, Jason Gorman, Kai Xu, Gwo‐Yu Chuang, Chen‐Hsiang Shen +33 more

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain

mAbs(2023)10.1080/19420862.2023.2223350

N/A

0DataRank · unranked

9 citations

Amarendra Pegu, Eun Sung Yang, Baoshan Zhang, Michael F. Bender, Mangaiarkarasi Asokan +14 more

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad069

N/A

0DataRank · unranked

10 citations

Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy +19 more

Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.06.565765

N/A

0DataRank · unranked

9 citations

Barbara J. Flynn, Shayne F. Andrew, Dillon R. Flebbe, Anna Mychalowych, Evan Lamb +42 more

Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains

Research Square(2023)10.21203/rs.3.rs-3360161/v1

N/A

0DataRank · unranked

0 citations

Shixia Wang, Kun‐Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu +17 more

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates

Nature Immunology(2024)10.1038/s41590-024-01951-5

N/A

0DataRank · unranked

50 citations

Barbara J. Flynn, Shayne F. Andrew, Josue Marquez, Dillon R. Flebbe, Anna Mychalowych +43 more

Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques

Cell(2024)10.1016/j.cell.2024.10.003

N/A

0DataRank · unranked

28 citations

Cheng Cheng, James P. Di Santo, Chen‐Hsiang Shen, Tatsiana Bylund, Amy R. Henry +65 more